TipRanks
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market
8622
Huakang Biomedical Holdings Company Limited
RESEARCH TOOLSreports
Want to see HK:8622 full AI Analyst Report?

Huakang Biomedical Holdings Company Limited (8622) Ratios

0 Followers

Huakang Biomedical Holdings Company Limited Ratios

HK:8622's free cash flow for Q2 2026 was ¥0.64. For the 2026 fiscal year, HK:8622's free cash flow was decreased by ¥ and operating cash flow was ¥-0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.47 3.88 4.90 4.08 5.46
Quick Ratio
 3.24 3.60 4.66 3.82 5.14
Cash Ratio
 2.09 2.50 2.82 2.51 3.40
Solvency Ratio
 -0.10 -0.21 -0.23 -0.18 <0.01
Operating Cash Flow Ratio
 -0.37 -0.15 -0.27 >-0.01 0.13
Short-Term Operating Cash Flow Coverage
 -0.88 -0.61 -1.05 -0.02 0.91
Net Current Asset Value
¥ 39.62M¥ 41.83M¥ 43.55M¥ 39.14M¥ 43.55M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.07 0.06 0.08 0.03
Debt-to-Equity Ratio
 0.16 0.10 0.08 0.10 0.03
Debt-to-Capital Ratio
 0.14 0.09 0.07 0.09 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.35 1.30 1.21 1.28 1.17
Debt Service Coverage Ratio
 -0.71 -1.61 -1.14 -0.88 0.08
Interest Coverage Ratio
 -19.52 -32.59 -58.27 -139.45 -92.55
Debt to Market Cap
 0.09 0.02 0.04 0.07 0.02
Interest Debt Per Share
 0.02 0.01 <0.01 0.01 <0.01
Net Debt to EBITDA
 5.08 5.19 8.04 10.90 -167.16
Profitability Margins
Gross Profit Margin
61.26%62.83%67.32%65.34%66.77%
EBIT Margin
-26.18%-27.90%-19.76%-23.26%-11.65%
EBITDA Margin
-16.10%-21.82%-13.45%-10.35%0.74%
Operating Profit Margin
-25.03%-27.61%-19.76%-30.01%-20.09%
Pretax Profit Margin
-15.60%-17.73%-16.40%-23.48%-11.87%
Net Profit Margin
-15.58%-17.70%-16.40%-23.48%-12.14%
Continuous Operations Profit Margin
-15.60%-17.73%-16.40%-23.48%-12.14%
Net Income Per EBT
99.86%99.86%100.00%100.00%102.26%
EBT Per EBIT
62.32%64.19%82.98%78.23%59.08%
Return on Assets (ROA)
-7.65%-7.51%-6.38%-8.85%-4.63%
Return on Equity (ROE)
-10.11%-9.79%-7.69%-11.33%-5.44%
Return on Capital Employed (ROCE)
-16.33%-15.05%-9.27%-14.15%-8.99%
Return on Invested Capital (ROIC)
-14.33%-13.91%-8.62%-13.16%-8.71%
Return on Tangible Assets
-7.71%-7.60%-6.52%-9.15%-4.84%
Earnings Yield
-6.53%-2.56%-6.12%-14.34%-4.65%
Efficiency Ratios
Receivables Turnover
 2.69 2.68 2.55 2.54 2.67
Payables Turnover
 12.12 16.29 12.48 13.38 10.15
Inventory Turnover
 3.47 2.54 3.05 2.51 2.70
Fixed Asset Turnover
 3.62 3.30 2.80 2.53 3.06
Asset Turnover
 0.49 0.42 0.39 0.38 0.38
Working Capital Turnover Ratio
 0.81 0.66 0.60 0.59 0.57
Cash Conversion Cycle
 210.95 257.65 233.62 261.39 235.65
Days of Sales Outstanding
 135.84 136.15 143.20 143.50 136.46
Days of Inventory Outstanding
 105.22 143.90 119.67 145.17 135.14
Days of Payables Outstanding
 30.11 22.40 29.25 27.28 35.95
Operating Cycle
 241.06 280.05 262.87 288.67 271.60
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.01 >-0.01 >-0.01 >-0.01 <0.01
Free Cash Flow Per Share
 -0.01 >-0.01 -0.01 >-0.01 <0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.18 1.49 1.65 32.29 0.37
Dividend Paid and CapEx Coverage Ratio
 -5.49 -2.04 -1.54 -0.03 1.59
Capital Expenditure Coverage Ratio
 -5.49 -2.04 -1.54 -0.03 1.59
Operating Cash Flow Coverage Ratio
 -0.80 -0.45 -0.75 >-0.01 0.69
Operating Cash Flow to Sales Ratio
 -0.19 -0.08 -0.12 >-0.01 0.05
Free Cash Flow Yield
-9.30%-1.68%-7.43%-3.84%0.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -12.42 -39.07 -16.35 -6.98 -21.50
Price-to-Sales (P/S) Ratio
 2.38 6.93 2.68 1.64 2.61
Price-to-Book (P/B) Ratio
 1.58 3.83 1.26 0.79 1.17
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.74 -59.52 -13.45 -26.02 139.16
Price-to-Operating Cash Flow Ratio
 -12.70 -88.68 -22.21 -840.20 51.40
Price-to-Earnings Growth (PEG) Ratio
 0.51 -2.40 0.43 -0.08 0.78
Enterprise Value Multiple
 -9.72 -26.57 -11.89 -4.91 184.44
Enterprise Value
 50.94M 163.93M 40.56M 12.53M 34.67M
EV to EBITDA
 -9.73 -26.57 -11.89 -4.91 184.44
EV to Sales
 1.57 5.80 1.60 0.51 1.37
EV to Free Cash Flow
 -7.06 -49.80 -8.03 -8.08 73.00
EV to Operating Cash Flow
 -8.35 -74.20 -13.25 -261.05 26.96
Tangible Book Value Per Share
 0.09 0.10 0.11 0.12 0.13
Shareholders’ Equity Per Share
 0.10 0.10 0.11 0.12 0.14
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.02
Revenue Per Share
 0.06 0.06 0.05 0.06 0.06
Net Income Per Share
 >-0.01 >-0.01 >-0.01 -0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.02
Interest Burden
 0.60 0.64 0.83 1.01 1.02
Research & Development to Revenue
 0.16 0.14 0.11 0.10 0.10
SG&A to Revenue
 0.73 0.76 0.76 0.40 0.39
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.20 0.45 0.74 <0.01 -0.43
Currency in CNY